Viking Therapeutics Inc (VKTX)
51.63
+0.10
(+0.19%)
USD |
NASDAQ |
Nov 21, 16:00
53.17
+1.54
(+2.98%)
After-Hours: 05:22
Viking Therapeutics Shareholders Equity (Quarterly): 911.45M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 911.45M |
| June 30, 2024 | 920.98M |
| March 31, 2024 | 933.89M |
| December 31, 2023 | 348.42M |
| September 30, 2023 | 368.24M |
| June 30, 2023 | 386.12M |
| March 31, 2023 | 134.06M |
| December 31, 2022 | 145.32M |
| September 30, 2022 | 151.28M |
| June 30, 2022 | 165.23M |
| March 31, 2022 | 182.27M |
| December 31, 2021 | 201.88M |
| September 30, 2021 | 213.12M |
| June 30, 2021 | 224.97M |
| March 31, 2021 | 237.22M |
| December 31, 2020 | 244.34M |
| September 30, 2020 | 253.79M |
| June 30, 2020 | 261.95M |
| March 31, 2020 | 268.28M |
| December 31, 2019 | 277.12M |
| September 30, 2019 | 283.49M |
| Date | Value |
|---|---|
| June 30, 2019 | 288.35M |
| March 31, 2019 | 294.57M |
| December 31, 2018 | 297.75M |
| September 30, 2018 | 302.05M |
| June 30, 2018 | 140.36M |
| March 31, 2018 | 72.63M |
| December 31, 2017 | 13.46M |
| September 30, 2017 | 2.226M |
| June 30, 2017 | 6.588M |
| March 31, 2017 | 7.546M |
| December 31, 2016 | 8.043M |
| September 30, 2016 | 10.22M |
| June 30, 2016 | 12.79M |
| March 31, 2016 | 5.770M |
| December 31, 2015 | 8.725M |
| September 30, 2015 | 13.27M |
| June 30, 2015 | 17.39M |
| March 31, 2015 | -27.84M |
| December 31, 2014 | -22.13M |
| June 30, 2014 | -23.26M |
| March 31, 2014 | -0.4786M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
134.06M
Minimum
Mar 2023
933.89M
Maximum
Mar 2024
341.50M
Average
249.07M
Median
Shareholders Equity (Quarterly) Benchmarks
| Amgen Inc | 7.527B |
| Eli Lilly and Co | 14.24B |
| Pfizer Inc | 92.29B |
| Structure Therapeutics Inc | 896.80M |
| Altimmune Inc | 133.38M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 937.89M |
| Total Liabilities (Quarterly) | 26.44M |